C07C 271/64
Y being a hydrogen or a carbon atom
Official title: Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
C07C271/64 (Y being a hydrogen or a carbon atom) appears on 126 US grants and 69 published applications in this corpus.
Search patents in C07C- Granted patents
- 126
- Published applications
- 69
- Assignees
- 74
- Inventors
- 398
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 4 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 7 | 0 |
| 1994 | 0 | 0 |
| 1995 | 11 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 7 | 0 |
| 2001 | 7 | 4 |
| 2002 | 12 | 4 |
| 2003 | 5 | 7 |
| 2004 | 5 | 6 |
| 2005 | 3 | 4 |
| 2006 | 1 | 1 |
| 2007 | 2 | 2 |
| 2008 | 1 | 3 |
| 2009 | 0 | 2 |
| 2010 | 3 | 4 |
| 2011 | 1 | 1 |
| 2012 | 3 | 3 |
| 2013 | 1 | 3 |
| 2014 | 3 | 2 |
| 2015 | 2 | 1 |
| 2016 | 3 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 1 | 2 |
| 2021 | 3 | 1 |
| 2022 | 0 | 0 |
| 2023 | 1 | 6 |
| 2024 | 0 | 1 |
| 2025 | 2 | 6 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them18 Mar 2025US 12,251,445 B2Zevra Therapeutics, Inc.
- MASP-2 inhibitors and methods of use14 Jan 2025US 12,195,427 B2Omeros Corporation
- MASP-2 inhibitors and methods of use21 Feb 2023US 11,584,714 B2Omeros Corporation
- Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof13 Apr 2021US 10,975,049 B2Institute of Materia Medica, Chinese Academy of Medical Sciences
- Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof9 Mar 2021US 10,941,129 B2Institute of Materia Medica, Chinese Academy of Medical Sciences
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Masp-2 inhibitors and methods of use11 Dec 2025US 2025/0376443 A1Omeros Corporation
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them4 Dec 2025US 2025/0367299 A1Zevra Therapeutics, Inc.
- Masp-2 inhibitors and methods of use4 Dec 2025US 2025/0368604 A1Omeros Corporation
- Novel modulators of the melatonin receptors as well as method of manufacture and uses thereof6 Nov 2025US 2025/0339396 A1Cosmas Therapeutics Development Inc.
Most cited
By later US patents
- Lipid derivatives, their production and use76US 5,025,005 ATakeda Chemical Industries, Ltd. · 1991
- Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use66US 8,778,991 B2XenoPort, Inc. · 2014
- Biaryl compounds as serine protease inhibitors57US 6,699,994 B1BioCryst Pharmaceuticals, Inc. · 2004
- Urokinase inhibitors52US 6,258,822 B1Abbott Laboratories · 2001
- Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use46US 8,148,414 B2XenoPort, Inc. · 2012